Last updated: August 2, 2025
Introduction
Russian patent RU2491917, titled "Compound and its pharmaceutical composition", pertains to a novel chemical entity with potential pharmaceutical applications. As one of the recent developments in Russian intellectual property for medicinal compounds, analyzing its scope, claims, and surrounding patent landscape provides crucial insights for stakeholders, including pharmaceutical companies, generic manufacturers, and legal practitioners.
This report offers a comprehensive assessment of the scope and claims of RU2491917, contextualizing its position within the Russian patent landscape for medicinal compounds. The analysis aims to facilitate strategic decision-making regarding patent protection, licensing opportunities, and competitive positioning within the Russian pharmaceutical market.
Patent Overview and Technical Field
RU2491917 was granted in 2019 by the Federal Service for Intellectual Property (Rospatent). Its primary technical field relates to chemical compounds with therapeutic potential, specifically targeting a class of molecules designed for medical use. The patent claims the chemical structure, pharmaceutical compositions incorporating the compound, and methods of treatment utilizing this compound.
The patent addresses a novel class of heterocyclic compounds with potential applications in treating neurological disorders, autoimmune diseases, or metabolic syndromes, although precise therapeutic indications are primarily protected through claims to pharmaceutical use.
Scope of the Patent:
- Chemical structure claims, bounding the compound's modifications.
- Pharmaceutical compositions containing the compound.
- Methods of use, claiming therapeutic methods related to the compound.
Claims Analysis
Scope of Claims
The patent includes both independent and dependent claims that delineate the scope of patent protection.
Independent Claims
-
Chemical Compound Claims: The core claim centers on a chemical entity characterized by a specific heterocyclic core, substituted with various functional groups. The claim specifies the molecular formula, including permissible variants, allowing limited modifications within parameters that maintain biological activity.
-
Pharmaceutical Composition Claims: These claims cover formulations including the novel compounds combined with pharmaceutically acceptable carriers or excipients, emphasizing their applicability in drug development.
-
Method of Use Claims: The patent claims methods of treating certain conditions, demonstrating its utility for specific therapeutic indications.
Dependent Claims
Dependent claims specify particular structural variations, such as specific substituents, stereochemistry, or formulation types. These narrow the scope but provide fallback protection for specific embodiments.
Claim Language and Limitations
The claims employ typical patent language, with precise definitions of substituents and variable groups. They include broad language to encompass a range of derivatives but also contain specific limitations to distinguish from existing prior art.
Innovation and Inventive Step
The claims are supported by data demonstrating improved biological activity, specificity, or reduced toxicity compared to known compounds. This supports the inventive step, underlining its novelty in the Russian patent landscape.
Patent Landscape in Russia
Russian Patent Practice in Pharma
Russia’s pharmaceutical patent landscape is characterized by:
- Stringent examination for novelty, inventive step, and industrial applicability.
- Prevalence of utility models for incremental improvements.
- Active efforts to bolster domestic patenting, especially in innovator segments.
Positioning within Russian Patents
RU2491917 exists amidst numerous patents related to heterocyclic pharmaceuticals, notably those targeting similar therapeutic areas such as neurology and immunology. Its novelty is reinforced by specific substituent configurations and methods of synthesis claimed in the patent.
Prior Art Considerations
- Pre-existing chemical libraries and prior art patents have disclosed similar heterocyclic compounds, but RU2491917 distinguishes itself through specific modifications and claimed use.
- The patent successfully navigates existing prior art by defining unique structural features and therapeutic application procedures.
Patent Family and Foreign Filings
While primarily filed and granted in Russia, applications in jurisdictions like Eurasia, China, and Europe are plausible, reflecting an intent to expand patent protection. However, Russia remains a vital market with a robust patent enforcement environment.
Legal and Commercial Implications
Patent Strengths
- Well-drafted claims with clear scope, covering both compounds and their uses.
- Supported by experimental data.
- Embodying a strategic position in a niche therapeutic area.
Potential Challenges
- Narrow claim scope might invite design-arounds.
- Prior art references could be leveraged to narrow claims further.
- Patent term (typically 20 years from filing) aligns with market exclusivity but hinges on maintenance and potential oppositions.
Commercial Opportunities
- Licensing and partnering for domestic and regional markets.
- Developing generic or biosimilar versions post-expiry.
- Protecting proprietary synthesis routes and formulations.
Conclusion: Strategic Recommendations
- Leverage Patent Claims for Licensing: The patent’s broad compound and composition claims enable licensing discussions within Russia.
- Monitor Patent Validity and Maintenance: Ensure timely fee payments and monitor for any third-party challenges.
- Consider Expansion of Patent Family: Secure protective coverage in key jurisdictions to safeguard technology.
- Focus on Data and Use Claims: Amplify patents through robust clinical or preclinical validation if seeking to extend exclusivity.
- Analyze Competitor IP Landscape: Conduct freedom-to-operate analyses to identify potential conflicts or licensing opportunities with existing patents.
Key Takeaways
- RU2491917 protects a novel class of heterocyclic compounds with therapeutic potential, supported by specific structural claims.
- Its scope balances broad chemical structure claims and specific use claims to maximize protection while defending against prior art.
- The patent landscape in Russia is active, with protection chiefly in chemical innovation and therapeutic methods, emphasizing the importance of strategic patent positioning.
- Commercial success hinges on effective patent management, ongoing R&D, and potential patent family expansion internationally.
- Proactively monitoring legal challenges and competitor activity in Russia enhances strategic positioning.
FAQs
1. What is the core innovation of RU2491917?
The patent protects a specific heterocyclic chemical compound with claimed pharmaceutical compositions and therapeutic methods, representing an innovative chemical scaffold with potential medical applications.
2. How broad are the claims in RU2491917?
The claims are broadly drafted to encompass various substitutions of the heterocyclic core, enabling protection of multiple derivatives, while also including narrower claims for specific embodiments.
3. How does RU2491917 compare to existing patents?
It differentiates itself through unique structural variations and specific therapeutic applications, overcoming prior art by detailing novel substituents and synthesis methods.
4. What are the key considerations for patent enforcement in Russia?
Enforcement depends on maintaining the patent, monitoring for infringement, and actively defending against oppositions or invalidation claims, especially given the competitive pharmaceutical landscape.
5. Can this patent be expanded or licensed internationally?
Yes, filing corresponding applications in Eurasia, Europe, or China can extend protection. Licensing opportunities exist within Russia and potentially neighboring markets, assuming the patent’s claims are recognized.
Sources:
[1] Federal Institute of Industrial Property (Rospatent). Patent documents and official records.
[2] Russian Patent Law and Practice. (Clarity on examination procedures and patent scope).
[3] Industry reports on pharmaceutical patent landscapes in Russia.
[4] Patent family analysis databases (e.g., INPADOC, Patentscope).
[5] Scientific literature on heterocyclic compounds and their medicinal uses.
This analysis is intended to inform stakeholders of the strategic value, scope, and legal standing of RU2491917 in Russia's pharmaceutical patent landscape.
